ILCT PIPELINE RESEARCH ACCELERATION PROGRAMME
Up to £300,000 - April 7, 2026; Q&A session 1: Monday 23 February, 4pm (GMT); Q&A session 2: Thursday 26 March, 11am (GMT)
Cure Parkinson's, GBThe objective of this funding call is to accelerate the additional research required for therapeutic candidates to move forward into clinical studies. Applications investigating secukinumab in an alpha synuclein model of Parkinson’s are welcomed.
